Eisai seeks approval of rufinamide in Japan

Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for rufinamide as an adjunctive therapy for seizures associated with ...